Q0167 Dronabinol 2.5mg oral
Also known as: Marinol, dronabinol, THC synthetic
Dronabinol 2.5 milligram oral capsule formulation, a synthetic cannabinoid used for appetite stimulation and antiemetic effects.
In Plain Language
appetite stimulant; nausea medication
Clinical Context
Used for chemotherapy-induced nausea/vomiting and HIV/AIDS-related cachexia and anorexia. Standard dosing 2.5-5 mg twice daily, monitor for psychiatric effects.
RVU Information
CPT Q0167 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q0167?
CPT Q0167 (Dronabinol 2.5mg oral) is a Q Codes code. Dronabinol 2.5 milligram oral capsule formulation, a synthetic cannabinoid used for appetite stimulation and antiemetic effects.
Is Q0167 covered by insurance?
Q0167 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for chemotherapy-induced nausea/vomiting and HIV/AIDS-related cachexia and anorexia. Standard dosing 2.5-5 mg twice daily, monitor for psychiatric effects.
When is CPT Q0167 used?
Used for chemotherapy-induced nausea/vomiting and HIV/AIDS-related cachexia and anorexia. Standard dosing 2.5-5 mg twice daily, monitor for psychiatric effects.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.